BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 15316509)

  • 1. Heparin attenuates symptoms and mast cell degranulation induced by AMP nasal provocation.
    Zeng D; Prosperini G; Russo C; Spicuzza L; Cacciola RR; Di Maria GU; Polosa R
    J Allergy Clin Immunol; 2004 Aug; 114(2):316-20. PubMed ID: 15316509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of salbutamol on nasal symptoms and mast cell degranulation induced by adenosine 5' monophosphate nasal challenge.
    Russo C; Zeng D; Prosperini G; Spicuzza L; Guarino F; Polosa R
    Clin Exp Allergy; 2005 Sep; 35(9):1192-6. PubMed ID: 16164447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of fexofenadine on the early response to nasal allergen challenge.
    Allocco FT; Votypka V; deTineo M; Naclerio RM; Baroody FM
    Ann Allergy Asthma Immunol; 2002 Dec; 89(6):578-84. PubMed ID: 12487223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histamine releasability after adenosine challenge in subjects with allergic and non-allergic rhinitis: possible implications for mast cell priming.
    Polosa R; Pagano C; Low JL; Church MK; Crimi N
    Ann Ital Med Int; 1999; 14(2):86-93. PubMed ID: 10399370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basophil and eosinophil accumulation and mast cell degranulation in the nasal mucosa of patients with hay fever after local allergen provocation.
    KleinJan A; McEuen AR; Dijkstra MD; Buckley MG; Walls AF; Fokkens WJ
    J Allergy Clin Immunol; 2000 Oct; 106(4):677-86. PubMed ID: 11031338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mast cell mediator release in nonasthmatic subjects after endobronchial adenosine challenge.
    Crummy F; Livingston M; Ennis M; Heaney LG
    J Allergy Clin Immunol; 2004 Jul; 114(1):34-9. PubMed ID: 15241341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histamine and tryptase in nasal lavage fluid after allergen challenge: effect of 1 week of pretreatment with intranasal azelastine or systemic cetirizine.
    Jacobi HH; Skov PS; Poulsen LK; Malling HJ; Mygind N
    J Allergy Clin Immunol; 1999 May; 103(5 Pt 1):768-72. PubMed ID: 10329808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low dose clemastine inhibits sneezing and rhinorrhea during the early nasal allergic reaction.
    Chung JH; deTineo ML; Naclerio RM; Sorrentino JV; Winslow CM; Baroody FM
    Ann Allergy Asthma Immunol; 1997 Mar; 78(3):307-12. PubMed ID: 9087158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting adenosine receptors in the treatment of allergic rhinitis: a randomized, double-blind, placebo-controlled study.
    Rimmer J; Peake HL; Santos CM; Lean M; Bardin P; Robson R; Haumann B; Loehrer F; Handel ML
    Clin Exp Allergy; 2007 Jan; 37(1):8-14. PubMed ID: 17210036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of histamine and adenosine 5'-monophosphate provocation on sputum neutrophils and related mediators in atopic patients.
    Pohl D; Beier J; Buhl R; Beeh KM
    Ann Allergy Asthma Immunol; 2005 Aug; 95(2):197-203. PubMed ID: 16136771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro diagnosis of chronic nasal inflammation.
    Kramer MF; Burow G; Pfrogner E; Rasp G
    Clin Exp Allergy; 2004 Jul; 34(7):1086-92. PubMed ID: 15248854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A role for tryptase in the activation of human mast cells: modulation of histamine release by tryptase and inhibitors of tryptase.
    He S; Gaça MD; Walls AF
    J Pharmacol Exp Ther; 1998 Jul; 286(1):289-97. PubMed ID: 9655871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapy and mast cell activation.
    Carlos AG; Carlos ML; Santos MA; Pedro E; Santos S; Lopes-Pregal A
    Allerg Immunol (Paris); 1998 Oct; 30(8):257-8. PubMed ID: 9846195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diesel exhaust particles directly induce activated mast cells to degranulate and increase histamine levels and symptom severity.
    Diaz-Sanchez D; Penichet-Garcia M; Saxon A
    J Allergy Clin Immunol; 2000 Dec; 106(6):1140-6. PubMed ID: 11112898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of mast cell tryptase by inhaled APC 366 attenuates allergen-induced late-phase airway obstruction in asthma.
    Krishna MT; Chauhan A; Little L; Sampson K; Hawksworth R; Mant T; Djukanovic R; Lee T; Holgate S
    J Allergy Clin Immunol; 2001 Jun; 107(6):1039-45. PubMed ID: 11398082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nasal inflammatory mediators and specific IgE production after nasal challenge with grass pollen in local allergic rhinitis.
    Rondón C; Fernández J; López S; Campo P; Doña I; Torres MJ; Mayorga C; Blanca M
    J Allergy Clin Immunol; 2009 Nov; 124(5):1005-11.e1. PubMed ID: 19796796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Degranulation of nasal epithelial mast cells after challenge of allergen. An electron microscopic study with serial sections.
    Kawabori S; Unno T
    J Submicrosc Cytol; 1983 Jul; 15(3):823-32. PubMed ID: 6876230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitors of tryptase as mast cell-stabilizing agents in the human airways: effects of tryptase and other agonists of proteinase-activated receptor 2 on histamine release.
    He S; Aslam A; Gaça MD; He Y; Buckley MG; Hollenberg MD; Walls AF
    J Pharmacol Exp Ther; 2004 Apr; 309(1):119-26. PubMed ID: 14722328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventing bronchoconstriction in exercise-induced asthma with inhaled heparin.
    Ahmed T; Garrigo J; Danta I
    N Engl J Med; 1993 Jul; 329(2):90-5. PubMed ID: 8510708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for the involvement of free light chain immunoglobulins in allergic and nonallergic rhinitis.
    Powe DG; Groot Kormelink T; Sisson M; Blokhuis BJ; Kramer MF; Jones NS; Redegeld FA
    J Allergy Clin Immunol; 2010 Jan; 125(1):139-45.e1-3. PubMed ID: 19818484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.